Enovix Corp Files 8-K: Regulation FD & Financials

Ticker: ENVX · Form: 8-K · Filed: 2025-04-03T00:00:00.000Z

Sentiment: neutral

Topics: disclosure, financials, corporate-filing

Related Tickers: ENVX

TL;DR

Enovix filed an 8-K on April 3rd for an April 1st event, covering Reg FD and financials.

AI Summary

Enovix Corporation filed an 8-K on April 3, 2025, reporting an event on April 1, 2025. The filing is a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934. It includes information on Regulation FD Disclosure and Financial Statements and Exhibits.

Why It Matters

This 8-K filing indicates Enovix Corporation is providing updates on regulatory disclosures and financial information, which is crucial for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.

Key Players & Entities

FAQ

What is the primary purpose of this Form 8-K filing for Enovix Corporation?

The primary purpose is to report an event that occurred on April 1, 2025, and to satisfy filing obligations under Section 13 or 15(d) of the Securities Exchange Act of 1934, including Regulation FD Disclosure and Financial Statements and Exhibits.

When was this 8-K filing submitted to the SEC?

The filing was submitted on April 3, 2025.

What is the principal executive office address for Enovix Corporation?

The principal executive office is located at 3501 W Warren Avenue, Fremont, California, 94538.

What specific items are being reported in this 8-K filing?

The filing specifically mentions 'Regulation FD Disclosure' and 'Financial Statements and Exhibits' as items of information.

What is the Commission File Number for Enovix Corporation?

The Commission File Number for Enovix Corporation is 001-39753.

From the Filing

0001828318-25-000087.txt : 20250403 0001828318-25-000087.hdr.sgml : 20250403 20250403163929 ACCESSION NUMBER: 0001828318-25-000087 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250401 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250403 DATE AS OF CHANGE: 20250403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enovix Corp CENTRAL INDEX KEY: 0001828318 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] ORGANIZATION NAME: 04 Manufacturing EIN: 853174357 FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39753 FILM NUMBER: 25810205 BUSINESS ADDRESS: STREET 1: 3501 W. WARREN AVENUE CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 510 695-2350 MAIL ADDRESS: STREET 1: 3501 W. WARREN AVENUE CITY: FREMONT STATE: CA ZIP: 94538 FORMER COMPANY: FORMER CONFORMED NAME: Rodgers Silicon Valley Acquisition Corp DATE OF NAME CHANGE: 20201014 8-K 1 envx-20250401.htm 8-K envx-20250401 0001828318 False 0001828318 2025-04-01 2025-04-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter)   Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 3501 W Warren Avenue Fremont , California   94538 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: ( 510 ) 695-2350 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share ENVX The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01 Regulation FD Disclosure. On April 3, 2025, Enovix Corporation (the “Company”) issued a press release announcing the acquisition of battery cell manufacturing assets from SolarEdge located in South Korea. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Item 7.01, including the exhibit incorporated herein by reference, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by spe

View on Read The Filing